Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury.

Previous studies of myocardial ischemia suggest that complement activation may play a central role in the inflammatory response during reperfusion. Our previous work has demonstrated neutrophil chemotactic activity to be present in reperfusion canine cardiac lymph after myocardial ischemia and infarction. To evaluate the contribution of the complement-dependent anaphylatoxin C5a to this neutrophil chemotactic activity, rabbit antiserum to canine C5a was prepared. At dilutions > 1:500 but < 1:2,000, the antiserum abolished the ability of zymosan-activated dog serum to induce a ruffled, bipolar morphology in isolated neutrophils used as a bioassay of chemotactic stimulation. This antiserum did not affect similar morphological changes in neutrophils exposed to platelet activating factor (10(-7)-10(-6) M) or recombinant human interleukin-8 (10(-9)-10(-8) M); thus, we deemed it functionally specific for canine C5a. In a pattern similar to what we previously reported, cardiac lymph collected before a 1-hour ligation of the left circumflex coronary artery had little ability to alter the morphology of canine neutrophils (shape change index, 11.3 +/- 4.6, mean +/- SEM; n = 7), but by 1 hour of reperfusion, lymph activated neutrophils significantly in five of seven dogs (mean shape change index, 72.6 +/- 17.7; p < 0.01). At 2 hours of reperfusion, neutrophil activation by lymph occurred in six of seven dogs (mean shape change index, 103.1 +/- 22.2). At 3 hours of reperfusion, cardiac lymph of only three of six dogs caused neutrophil activation, and at 4 hours of reperfusion, this activity was evident in lymph from only two of five dogs.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  W. Dreyer,et al.  Neutrophil Accumulation in Ischemic Canine Myocardium: Insights Into Time Course, Distribution, and Mechanism of Localization During Early Reperfusion , 1991, Circulation.

[2]  P. Ward,et al.  THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS , 1971, The Journal of experimental medicine.

[3]  A. M. Lefer,et al.  Thromboxane Is Produced in Response to Intracoronary Infusions of Complement C5a in Pigs Cyclooxygenase Blockade Does Not Reduce the Myocardial Ischemia and Leukocyte Accumulation , 1989, Circulation research.

[4]  Giclas Pc,et al.  In vitro activation of complement by isolated human heart subcellular membranes. , 1979 .

[5]  J. Salmon,et al.  Leukocyte-derived metabolites of arachidonic acid in ischemia-induced myocardial injury. , 1987, Federation proceedings.

[6]  C. Gerard,et al.  Anaphylatoxin from the fifth component of porcine complement. Purification and partial chemical characterization. , 1979, The Journal of biological chemistry.

[7]  R. O'rourke,et al.  Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. , 1975, The Journal of clinical investigation.

[8]  C. Smith,et al.  The role of leukocytes in ischemic damage, reperfusion injury and repair of the myocardium , 1990 .

[9]  S. Calvano,et al.  Myocardial reperfusion injury. Platelet-activating factor stimulates polymorphonuclear leukocyte hydrogen peroxide production during myocardial reperfusion. , 1991, The Journal of thoracic and cardiovascular surgery.

[10]  B. Tack,et al.  Fifth component of human complement: purification from plasma and polypeptide chain structure. , 1979, Biochemistry.

[11]  A. M. Lefer,et al.  Role of platelet activating factor in propagation of cardiac damage during myocardial ischemia. , 1988, The Journal of pharmacology and experimental therapeutics.

[12]  M. Entman,et al.  Selective Accumulation of the First Component of Complement and Leukocytes in Ischemic Canine Heart Muscle: A Possible Initiator of an Extra Myocardial Mechanism of Ischemic Injury , 1985, Circulation research.

[13]  L. McManus,et al.  Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. , 1988, Circulation.

[14]  M. Schork,et al.  The Effect of Ibuprofen on Accumulation of Indium‐111‐labeled Platelets and Leukocytes in Experimental Myocardial Infarction , 1982, Circulation.

[15]  T. Plummer,et al.  A potent mercapto bi-product analogue inhibitor for human carboxypeptidase N. , 1981, Biochemical and biophysical research communications.

[16]  C. Gerard,et al.  Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement. , 1980, The Journal of biological chemistry.

[17]  M. Olson,et al.  Characterization of the binding of purified human C1q to heart mitochondrial membranes. , 1981, The Journal of biological chemistry.

[18]  R. Engler,et al.  Thromboxane A2 and peptidoleukotrienes contribute to the myocardial ischemia and contractile dysfunction in response to intracoronary infusion of complement C5a in pigs. , 1990, Circulation research.

[19]  M. Chiariello,et al.  Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. , 1978, The Journal of clinical investigation.

[20]  M. Entman,et al.  Creatine kinase and phosphorylase in cardiac lymph: coronary occlusion and reperfusion. , 1985, The American journal of physiology.

[21]  J. Longhurst,et al.  Role of thromboxane A2 in the cardiovascular response to intracoronary C5a. , 1990, Circulation research.

[22]  M. Nonaka,et al.  The complement system in rainbow trout (Salmo gairdneri). II. Purification and characterization of the fifth component (C5). , 1981, Journal of immunology.

[23]  T. Kinoshita,et al.  Fifth component of guinea pig complement: purification and characterization. , 1981, Journal of immunology.

[24]  H. Tai,et al.  Hypoxia provokes leukotriene-dependent neutrophil sequestration in perfused rabbit hearts. , 1987, The Journal of pharmacology and experimental therapeutics.

[25]  M. Entman,et al.  Myocardial Ischemia: Platelet and Thromboxane Concentrations in Cardiac Lymph and the Effects of Ibuprofen and Prostacyclin , 1986, Circulation research.

[26]  A. Huber,et al.  Regulation of transendothelial neutrophil migration by endogenous interleukin-8. , 1991, Science.

[27]  C. Smith,et al.  Motility and adhesiveness in human neutrophils. Effects of chemotactic factors. , 1979, The Journal of clinical investigation.

[28]  G. Carter,et al.  Chemical synthesis of a gene encoding the human complement fragment C5a and its expression in Escherichia coli. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. O'rourke,et al.  Antibody-independent activation of human C1 after interaction with heart subcellular membranes. , 1973, Journal of immunology.

[30]  M. Entman,et al.  Molecular Basis of Complement Activation in Ischemic Myocardium: Identification of Specific Molecules of Mitochondrial Origin That Bind Human Clq and Fix Complement , 1989, Circulation research.

[31]  J. Mehta,et al.  Neutrophils as potential participants in acute myocardial ischemia: relevance to reperfusion. , 1988, Journal of the American College of Cardiology.

[32]  M. Olson,et al.  In vitro activation of complement by isolated human heart subcellular membranes. , 1979, Journal of immunology.

[33]  M. Entman,et al.  Mechanism of Complement Activation After Coronary Artery Occlusion: Evidence That Myocardial Ischemia in Dogs Causes Release of Constituents of Myocardial Subcellular Origin That Complex With Human C1q In Vivo , 1988, Circulation research.

[34]  G. R. Carson,et al.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.